PerkinElmer
GenomeWeb Index Down in May as NanoString Technologies Falls 30 Percent From April
The GenomeWeb Index underperformed the Dow Jones, the Nasdaq, and the Nasdaq Biotechnology Index last month.
In Brief This Week: Bio-Rad, 10x Genomics, IsoPlexis, 23andMe, PerkinElmer, LifeBit Biotech, More
News items for the week of May 24, 2021.
PerkinElmer Preliminary Q1 Revenues Grow 98 Percent; FDA Issues EUA for PCR COVID-19 Test
Core revenues were up 10 percent organically, while COVID-19 testing contributed $535 million to revenues in Q1 2021.
Euroimmun to Sell Oncgnostics Cervical Cancer Test in Certain Parts of Europe
Oncgnostics also expects the test to be approved by regulators in Canada and to be sold there by the end of the year.
PerkinElmer to Offer $800M in Senior Notes
The firm plans to use $561 million of the net proceeds to fund the majority of its planned $591 million acquisition of Oxford Immunotec.
Feb 2, 2021
PerkinElmer Q4 Revenues Spike 68 Percent
Jan 11, 2021
PerkinElmer Q4 Revenues Expected to Rise 66 Percent
Jan 7, 2021
PerkinElmer to Buy Oxford Immunotec for $591M
Nov 2, 2020
PerkinElmer to Buy Horizon Discovery for $383M
Oct 28, 2020
PerkinElmer Q3 Revenues Spike 36 Percent
Jul 29, 2020
Jul 28, 2020